JAZZ
ANALYST COVERAGE30 analysts
BUY
-1.0%downside to target
L $219.00
Med $237.00consensus
H $307.00
Buy
2790%
Hold
310%
27 Buy (90%)3 Hold (10%)0 Sell (0%)
Full report →
PRICE
Prev Close
239.01
Open
241.82
Day Range236.29 – 241.82
236.29
241.82
52W Range105.00 – 242.18
105.00
242.18
98% of range
VOLUME & SIZE
Avg Volume
1.0M
FUNDAMENTALS
P/E Ratio
1995.0x
Premium valuation
EPS (TTM)
Div Yield
No dividend
Beta
0.67
Low vol
TECHNICAL
RSI (14)
81
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19

JAZZ News

About

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Bruce Cozadd
Country
Ireland
Patricia CarrSenior Vice President & Chief Accounting Officer
Neena PatilExecutive Vice President & Chief Legal Officer
Mary Elizabeth HendersonSenior Vice President of Technical Operations
George Christopher EliadesSenior Vice President & Chief Transformation Officer
Jed BlackSenior Vice President of Sleep & CNS Medicine
Robert IannoneExecutive Vice President, Chief Medical Officer and Global Head of Research & Development
Bruce C. CozaddCo-Founder & Chairman
John MillerSenior Vice President of Corporate Strategy
Philip L. JohnsonExecutive Vice President & Chief Financial Officer
Heidi MannaExecutive Vice President & Chief People Officer
Renee D. GalaPresident, Chief Executive Officer & Director
Samantha PearceExecutive Vice President & Chief Commercial Officer
Jack W. SpinksExecutive Director of Investor Relations